T. Rowe Price Investment Management, Inc. Elanco Animal Health Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 31,510,014 shares of ELAN stock, worth $665 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
31,510,014
Previous 19,554,942
61.14%
Holding current value
$665 Million
Previous $279 Million
127.26%
% of portfolio
0.39%
Previous 0.18%
Shares
9 transactions
Others Institutions Holding ELAN
# of Institutions
459Shares Held
491MCall Options Held
780KPut Options Held
1.08M-
Dodge & Cox San Francisco, CA82.8MShares$1.75 Billion0.96% of portfolio
-
Primecap Management CO Pasadena, CA50MShares$1.05 Billion0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.02 Billion0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX24.7MShares$521 Million0.11% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$491 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...